MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
HER2/EGFR in Cancer Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,303 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,303 works in the cohort · of 4,299,418page 4 of 27

Labels cover 3 of 1,303 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,303 of 1,303 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis
Galileo A. Gonzalez-Conchas, Laura Rodríguez‐Romo, David Hernández‐Barajas, Juan Francisco González-Guerrero, Iván A. Rodríguez-Fernández, Adrian Manuel Verdines-Perez +6 more
2017· review· en· Cancer Treatment Reviews· Medicine
distilled prediction:candidate · metaepi_narrow+metaepi_broad+insufficient_payloadconsensus · metaepi_narrow
94
citations
aboutno affunlabeled
Systematic Review of HER2 Breast Cancer Testing
Marta Cuadros, Román Villegas
2008· review· en· Applied immunohistochemistry & molecular morphology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
88
citations
afffundunlabeled
Treatment of HER-2/<b> <i>neu</i> </b> Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/<b> <i>neu</i> </b> and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction
Corinna Warburton, Wieslawa H. Dragowska, Karen A. Gelmon, Stephen Chia, Hong Yan, Dana Masin +3 more
2004· article· en· Clinical Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
81
citations
← previousnext →

How this was built: Screen · Findings · About